BUILD Study

JRCT ID: jRCT1031230453

Registered date:19/11/2023

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: gastric cancer, breast cancer
• Date of first enrollment: 19/11/2023
• Study type: Observational

Outcome(s)

• Primary Outcome: Presence or absence of ILD

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable

Include criteria

1) Patients with breast or gastric cancer who are scheduled to start or have started their first T-DXd treatment in January 2022 or later.
2) Written consent for this study has been obtained from the patient.

Exclude criteria

1) Patients with a history of interstitial lung disease or undeniable on pre-enrollment testing
2) Patients participating in a clinical trial
3) Patients who are deemed inappropriate by the principal investigator or sub investigator

Related Information

• Primary Sponsor: Yasunaga Masahiro